New injection trial aims to tame deadly cholesterol in teens
NCT ID NCT07473843
Summary
This study is testing an experimental injection called zodasiran in adolescents aged 12 to 18 who have a rare, severe genetic cholesterol disorder called homozygous familial hypercholesterolemia (HoFH). The main goal is to see if the injection safely lowers their 'bad' LDL cholesterol over 12 months, even while they are on their current best cholesterol-lowering treatments. It is a single-arm study, meaning all participants will receive the active drug.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.